Induction of memory-like dendritic cell responses in vivo

Dendritic cells (DCs), a vital component of the innate immune system, are considered to lack antigen specificity and be devoid of immunological memory. Strategies that can induce memory-like responses from innate cells can be utilized to elicit protective immunity in immune deficient persons. Here we utilize an experimental immunization strategy to modulate DC inflammatory and memory-like responses against an opportunistic fungal pathogen that causes significant disease in immunocompromised individuals. Our results show that DCs isolated from protectively immunized mice exhibit enhanced transcriptional activation of interferon and immune signaling pathways. We also show long-term memory-like cytokine responses upon subsequent challenge with the fungal pathogen that are abrogated with inhibitors of specific histone modifications. Altogether, our study demonstrates that immunization strategies can be designed to elicit memory-like DC responses against infectious disease.

Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.

Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals) For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Give P values as exact values whenever suitable.

For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated Our web collection on statistics for biologists contains articles on many of the points above.

Software and code
Policy information about availability of computer code Data collection Flow Cytometry: BD FACSDiva software Intracellular Flow Cytometry: ImageStreamX IDEAS® 6.2 software (Millipore, Burlington, MA) No custom code/software was used Data analysis Statistics: GraphPad Prism version 5.00 for Windows (GraphPad Prism Software, San Diego California) Gene ontology analysis: DAVID functional analysis tool Functional pathway and network analyse: Ingenuity Pathway Analysis (IPA) (Qiagen, Germantown, MD) No custom code/software was used For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.

Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: -Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability The RNA-Seq results presented in this manuscript have been submitted to the Sequence Read Archive under accession number SRP120338SUB310649 [https:// www.ncbi.nlm.nih.gov/sra/?term=SRP120338]. The authors declare that all data supporting the findings of this study are available within the article and its supplementary information files or from the corresponding author upon reasonable request.

nature research | reporting summary
October 2018 Field-specific reporting Please select the one below that is the best fit for your research. If you are not sure, read the appropriate sections before making your selection.

Life sciences Behavioural & social sciences Ecological, evolutionary & environmental sciences
For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf

Life sciences study design
All studies must disclose on these points even when the disclosure is negative.

Sample size
Sample size was determined to obtain sufficient quantity of cells/material to perform experiments (i.e., obtain RNA or cells to perform cell culture experiments) and numbers of mice per group also done in consideration of group sizes sufficient to support our conclusions with statistical significance. Power analysis was performed when appropriate based on previous studies to detect a 10% change with alpha of 0.05.

Data exclusions No data were excluded from analysis
Replication Independent experiments were successfully replicated at least twice and more than twice in most cases. The exact numbers of biologically independent repetitions are provided in the Methods section and/or Figure Legends of the manuscript. Controls were compared to previous results of similar studies to confirm reproducibility of data when possible. Observations appeared to be reproducible and are reported as observed.
Randomization Mice were randomly assigned to groups and these groupings were maintained throughout the individual experiments in order to comply with the experimental design (immunized vs. mock-immunized).

Blinding
Investigators were not blinded as to mouse group allocations (not a clinical study) or collections as we needed to remain mindful of immunization groups to comply with study design and to ensure appropriate handling and data acquisition. Nonetheless, more than one scientist performed the reported experiments and analyzed the data independently. Also, data analysis was performed by computer-based methods and no data was excluded from study. Thus, blinding was not necessary to our studies.

Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response.

Validation
No customized antibodies were utilized in this study. Validation data of the antibodies purchased from commercial vendors are available on the vendor's web sites and/or data sheets that accompanied the antibodies. Murine cells known to be positive for target antigens/proteins were used to validate antibodies used for flow cytometry.

Eukaryotic cell lines
Policy information about cell lines

Cell line source(s)
State the source of each cell line used.

Authentication
Describe the authentication procedures for each cell line used OR declare that none of the cell lines used were authenticated.

Mycoplasma contamination
Confirm that all cell lines tested negative for mycoplasma contamination OR describe the results of the testing for mycoplasma contamination OR declare that the cell lines were not tested for mycoplasma contamination.

Commonly misidentified lines (See ICLAC register)
Name any commonly misidentified cell lines used in the study and provide a rationale for their use.

Palaeontology Specimen provenance
Provide provenance information for specimens and describe permits that were obtained for the work (including the name of the issuing authority, the date of issue, and any identifying information).

Specimen deposition
Indicate where the specimens have been deposited to permit free access by other researchers.

Dating methods
If new dates are provided, describe how they were obtained (e.g. collection, storage, sample pretreatment and measurement), where they were obtained (i.e. lab name), the calibration program and the protocol for quality assurance OR state that no new dates are provided.
Tick this box to confirm that the raw and calibrated dates are available in the paper or in Supplementary Information.

Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research

Ethics oversight
Identify the organization(s) that approved the study protocol.
Note that full information on the approval of the study protocol must also be provided in the manuscript.

Clinical data
Policy information about clinical studies All manuscripts should comply with the ICMJE guidelines for publication of clinical research and a completed CONSORT checklist must be included with all submissions.

Clinical trial registration
Provide the trial registration number from ClinicalTrials.gov or an equivalent agency.

October 2018
further analyzed for the uptake of live/dead yellow stain to determine live vs. dead cells. From live cells, cells were gated on CD45+ cell expression. For data analyses, 100,000 events (cells) were evaluated from a predominantly leukocyte population identified by back gating from CD45+ stained cells. The absolute number of total dendritic cells was quantified by multiplying the total number of cells observed by hemacytometer counting by the percentage of CD45+ cells determined by flow cytometry.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.

Magnetic resonance imaging
Experimental design